Adicet Bio, Inc.
Symbol: ACET
NASDAQ
1.69
USDDzisiejsza cena rynkowa
-0.5143
Wskaźnik P/E
0.0002
Wskaźnik PEG
138.87M
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Adicet Bio, Inc. (ACET) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 780.07 | 159.7 | 257.7 | 277.5 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 1.23 | 0 | 0.4 | 0.2 | ||||||||||||||||
balance-sheet.row.inventory | 6.39 | 0 | 2.6 | 4.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 3.94 | 2.6 | 0.4 | 0 | ||||||||||||||||
balance-sheet.row.total-current-assets | 791.62 | 162.3 | 261 | 282.4 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 188.76 | 44.2 | 49 | 35 | ||||||||||||||||
balance-sheet.row.goodwill | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | -0.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 3.85 | 0.8 | 1.2 | 2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 231.54 | 45 | 69.7 | 56.5 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1023.16 | 207.3 | 330.7 | 338.9 | ||||||||||||||||
balance-sheet.row.account-payables | 12.56 | 2.6 | 4.4 | 3.3 | ||||||||||||||||
balance-sheet.row.short-term-debt | 12.34 | 3.2 | 2.5 | 1.6 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 76.52 | 17.7 | 18.5 | 19.4 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 51.09 | 13.4 | 12.8 | 6.7 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 77.04 | 17.8 | 18.6 | 19.5 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 85.64 | 17.7 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.total-liab | 153.03 | 37.1 | 38.4 | 35.8 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 338.9 | ||||||||||||||||
balance-sheet.row.common-stock | 0.02 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.retained-earnings | -1302.45 | -380.8 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | -338.9 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1637.35 | 550.9 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 487.95 | 207.3 | -199.8 | -132.5 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 487.95 | - | - | - | ||||||||||||||||
Total Investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.total-debt | 88.86 | 20.9 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.net-debt | -691.21 | -138.8 | -236.6 | -256.6 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -142.66 | -142.7 | -69.8 | -62 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.1 | 6.1 | 2.6 | 1.5 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 9.71 | -34.1 | 0 | 1.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 20.26 | 20.3 | 17.1 | 12.5 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0.25 | 0.3 | 2.7 | -6.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0.2 | 0 | ||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 2 | ||||||||||||||||
cash-flows.row.account-payables | -1.68 | -1.7 | 1.7 | 1.1 | ||||||||||||||||
cash-flows.row.other-working-capital | 1.94 | 1.9 | 0.8 | -9.2 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 12.62 | 56.5 | 2.6 | 1.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -93.72 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 10.3 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -4.46 | -4.5 | -16.8 | -2.8 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0.39 | 0.4 | 43.4 | 238.1 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.15 | -0.1 | -3.2 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0.08 | -0.1 | -1.9 | 4.6 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0.24 | 0.2 | 41.5 | 242.7 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -97.94 | -97.9 | -20 | 188.8 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 780.07 | 159.7 | 257.7 | 277.7 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 878.01 | 257.7 | 277.7 | 88.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -93.72 | -93.7 | -44.8 | -51.1 | ||||||||||||||||
cash-flows.row.capital-expenditure | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.free-cash-flow | -98.18 | -98.2 | -61.5 | -64.1 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 25 | 9.7 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 8.14 | 6.1 | 5 | 0 | ||||||||||||||||
income-statement-row.row.gross-profit | -8.14 | -6.1 | 20 | 9.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 106.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 26.53 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.operating-expenses | 130.89 | 126.5 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 132.58 | 132.6 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.interest-income | 9.98 | 10 | 3.8 | 0.1 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 7.3 | 6.1 | 2.8 | -0.5 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -120.41 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -152.04 | -132.6 | -72.6 | -61.4 | ||||||||||||||||
income-statement-row.row.income-before-tax | -142.66 | -142.7 | -69.8 | -62.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -1.51 | 0 | -2.8 | -0.1 | ||||||||||||||||
income-statement-row.row.net-income | -141.4 | -142.7 | -67 | -62 |
Często zadawane pytania
Ile wynosi Adicet Bio, Inc. (ACET) aktywów ogółem?
Adicet Bio, Inc. (ACET) całkowite aktywa to 207295000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.000.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -2.281.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.000.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.000.
Co to jest Adicet Bio, Inc. (ACET) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -142658000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 20924000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 126478000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 159711000.000.